Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the long-term safety and efficacy of imidafenacin.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ono Pharmaceutical Co. Ltd
• Collaborator: Kyorin Pharmaceutical Co.,Ltd

Criteria

Inclusion Criteria:

• Men and Woman equal or > 20 years old

• Patients with urgency, urinary frequency and urgency incontinence

Exclusion Criteria:

• Patients with genuine stress incontinence

• Patients suffering from complications such as bladder tumor, urinary tract stone and symptomatic urinary tract infection

• Patients suffering from complications contraindicating the use of antimuscarinic medication

• Patients with polyuria